Literature DB >> 26711035

Ebola virus mediated infectivity is restricted in canine and feline cells.

Ziying Han1, Stephen M Bart2, Gordon Ruthel1, Nathan H Vande Burgt2, Kathleen M Haines2, Susan W Volk1, Charles H Vite1, Bruce D Freedman1, Paul Bates2, Ronald N Harty3.   

Abstract

Ebolaviruses and marburgviruses belong to the Filoviridae family and often cause severe, fatal hemorrhagic fever in humans and non-human primates. The magnitude of the 2014 outbreak in West Africa and the unprecedented emergence of Ebola virus disease (EVD) in the United States underscore the urgency to better understand the dynamics of Ebola virus infection, transmission and spread. To date, the susceptibility and possible role of domestic animals and pets in the transmission cycle and spread of EVD remains unclear. We utilized infectious VSV recombinants and lentivirus pseudotypes expressing the EBOV surface glycoprotein (GP) to assess the permissiveness of canine and feline cells to EBOV GP-mediated entry. We observed a general restriction in EBOV-mediated infection of primary canine and feline cells. To address the entry mechanism, we used cells deficient in NPC1, a host protein implicated in EBOV entry, and a pharmacological blockade of cholesterol transport, to show that an NPC1-dependent mechanism of EBOV entry is conserved in canine and feline cells. These data demonstrate that cells of canine and feline origin are susceptible to EBOV GP mediated infection; however, infectivity of these cells is reduced significantly compared to controls. Moreover, these data provide new insights into the mechanism of EBOV GP mediated entry into cells of canine and feline origin.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Ebola virus; Entry; Feline; Filovirus; Infectivity; Pseudotypes; Susceptibility; VSV recombinant

Mesh:

Substances:

Year:  2015        PMID: 26711035      PMCID: PMC4695692          DOI: 10.1016/j.vetmic.2015.11.011

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.246


  16 in total

1.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.

Authors:  Z Yang; R Delgado; L Xu; R F Todd; E G Nabel; A Sanchez; G J Nabel
Journal:  Science       Date:  1998-02-13       Impact factor: 47.728

5.  Functional characterization of Ebola virus L-domains using VSV recombinants.

Authors:  Takashi Irie; Jillian M Licata; Ronald N Harty
Journal:  Virology       Date:  2005-06-05       Impact factor: 3.616

6.  Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung.

Authors:  Maria Fe Medina; Gary P Kobinger; John Rux; Mehdi Gasmi; David J Looney; Paul Bates; James M Wilson
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

7.  Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical Probe.

Authors:  Kyungae Lee; Tao Ren; Marceline Côté; Berahman Gholamreza; John Misasi; Anna Bruchez; James Cunningham
Journal:  ACS Med Chem Lett       Date:  2012-12-19       Impact factor: 4.345

8.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

Authors:  Graham Simmons; Jacqueline D Reeves; Case C Grogan; Luk H Vandenberghe; Frédéric Baribaud; J Charles Whitbeck; Emily Burke; Michael J Buchmeier; Elizabeth J Soilleux; James L Riley; Robert W Doms; Paul Bates; Stefan Pöhlmann
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

9.  Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.

Authors:  Marceline Côté; John Misasi; Tao Ren; Anna Bruchez; Kyungae Lee; Claire Marie Filone; Lisa Hensley; Qi Li; Daniel Ory; Kartik Chandran; James Cunningham
Journal:  Nature       Date:  2011-08-24       Impact factor: 49.962

10.  Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor.

Authors:  Anuja Krishnan; Emily Happy Miller; Andrew S Herbert; Melinda Ng; Esther Ndungo; Sean P Whelan; John M Dye; Kartik Chandran
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

View more
  2 in total

1.  Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: A preliminary report.

Authors:  Brien K Haun; Varney Kamara; Abigail S Dweh; Kianalei Garalde-Machida; Saymajunkon S E Forkay; Melissa Takaaze; Madhuri Namekar; Teri Ann S Wong; Ayesha E R Bell-Gam Woto; Peter Humphreys; Ophelia I Weeks; Mosoka P Fallah; John M Berestecky; Vivek R Nerurkar; Axel T Lehrer
Journal:  PLoS Negl Trop Dis       Date:  2019-07-22

2.  Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.

Authors:  Kerstin Fischer; Roland Suluku; Sarah Katharina Fehling; Juliet Jabaty; Bashiru Koroma; Thomas Strecker; Martin H Groschup; Sandra Diederich
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.